To determine how copper nanoparticles (CuNPs) affect NSCLC cell lines by specifically targeting the PI3K/AKT/mTOR signaling pathway, we conducted Western blot analysis to observe changes in protein expression and phosphorylation. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.